Epidemiological Profile of Hepatocellular Carcinoma in Brazil
These findings highlight the critical need for improved epidemiological surveillance, expanded screening programs, and standardized diagnostic and treatment protocols for HCC in Brazil. The high prevalence of late-stage diagnoses and limited access to treatment underscores the urgent need to implement effective public health policies to promote early detection and improve disease management.
Authors
- Luiz Cláudio Santos Thuler (ORCID: https://orcid.org/0000-0003-2550-6537)
- Rogério Luiz dos Santos
- Guilherme Jorge Costa (ORCID: https://orcid.org/0000-0002-3699-0590)
- Leuridan Cavalcante Torres (ORCID: https://orcid.org/0000-0003-3517-6615)
- Regina Petrola Bastos Rocha (ORCID: https://orcid.org/0000-0003-0626-232X)
- Mário Rino Martins (ORCID: https://orcid.org/0000-0001-8705-8210)
- Lilian Faria de Melo
Institutions
- Hospital do Câncer III (BR)
- Hospital de Câncer de Pernambuco (BR)
- Instituto de Medicina Integral Professor Fernando Figueira (BR)
- Instituto Nacional de Câncer - INCA (BR)
Publication Details
- Journal
- In Vivo
- Published
- 2025-10-29
- DOI
- https://doi.org/10.21873/invivo.14162
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institut National Du Cancer
- Instituto Nacional do Câncer, Ministério da Saúde
- National Cancer Institute